BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 26573799)

  • 1. An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy.
    Tavaré R; Escuin-Ordinas H; Mok S; McCracken MN; Zettlitz KA; Salazar FB; Witte ON; Ribas A; Wu AM
    Cancer Res; 2016 Jan; 76(1):73-82. PubMed ID: 26573799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4
    Kristensen LK; Fröhlich C; Christensen C; Melander MC; Poulsen TT; Galler GR; Lantto J; Horak ID; Kragh M; Nielsen CH; Kjaer A
    Theranostics; 2019; 9(26):8221-8238. PubMed ID: 31754392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immuno-PET of Murine T Cell Reconstitution Postadoptive Stem Cell Transplantation Using Anti-CD4 and Anti-CD8 Cys-Diabodies.
    Tavaré R; McCracken MN; Zettlitz KA; Salazar FB; Olafsen T; Witte ON; Wu AM
    J Nucl Med; 2015 Aug; 56(8):1258-64. PubMed ID: 25952734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Production, Quality Control, and Characterization of ZED8, a CD8-Specific
    Gill H; Seipert R; Carroll VM; Gouasmat A; Yin J; Ogasawara A; de Jong I; Phan MM; Wang X; Yang J; Ilovich O; Marik J; Williams SP
    AAPS J; 2020 Jan; 22(2):22. PubMed ID: 31900688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PET-Tracer
    Griessinger CM; Olafsen T; Mascioni A; Jiang ZK; Zamilpa C; Jia F; Torgov M; Romero JM; Marchioni F; Satpayev D; Lee C; Zhang G; Nayak TK; Pincha M; Amann M; Mohan PLB; Richard M; Nicolini VG; Sam J; Claus C; Ferrara C; Brünker P; Bacac M; Umana P; Rüttinger D; Wilson IA; Gudas J; Klein C; Tessier JJL
    Cancer Res; 2020 Jul; 80(13):2903-2913. PubMed ID: 32409308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumors.
    Beckford Vera DR; Smith CC; Bixby LM; Glatt DM; Dunn SS; Saito R; Kim WY; Serody JS; Vincent BG; Parrott MC
    PLoS One; 2018; 13(3):e0193832. PubMed ID: 29513764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8
    Seo JW; Tavaré R; Mahakian LM; Silvestrini MT; Tam S; Ingham ES; Salazar FB; Borowsky AD; Wu AM; Ferrara KW
    Clin Cancer Res; 2018 Oct; 24(20):4976-4987. PubMed ID: 29967252
    [No Abstract]   [Full Text] [Related]  

  • 8. Established B16 tumors are rejected following treatment with GM-CSF-secreting tumor cell immunotherapy in combination with anti-4-1BB mAb.
    Li B; Lin J; Vanroey M; Jure-Kunkel M; Jooss K
    Clin Immunol; 2007 Oct; 125(1):76-87. PubMed ID: 17706463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immuno-PET Imaging of CD30-Positive Lymphoma Using 89Zr-Desferrioxamine-Labeled CD30-Specific AC-10 Antibody.
    Rylova SN; Del Pozzo L; Klingeberg C; Tönnesmann R; Illert AL; Meyer PT; Maecke HR; Holland JP
    J Nucl Med; 2016 Jan; 57(1):96-102. PubMed ID: 26514172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical PET imaging of bispecific antibody ERY974 targeting CD3 and glypican 3 reveals that tumor uptake correlates to T cell infiltrate.
    Waaijer SJ; Giesen D; Ishiguro T; Sano Y; Sugaya N; Schröder CP; de Vries EG; Lub-de Hooge MN
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32217763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immuno-PET Monitoring of Lymphocytes Using the CD8-Specific Antibody REGN5054.
    Tavaré R; Danton M; Giurleo JT; Makonnen S; Hickey C; Arnold TC; Kelly MP; Fredriksson F; Bruestle K; Hermann A; Ullman E; Edelmann KH; Potocky T; Dudgeon D; Bhatt NB; Doubrovin M; Barry T; Kyratsous CA; Gurer C; Tu N; Gartner H; Murphy A; Macdonald LE; Popke J; Mintz A; Griesemer A; Olson WC; Thurston G; Ma D; Kirshner JR
    Cancer Immunol Res; 2022 Oct; 10(10):1190-1209. PubMed ID: 35895745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immuno-PET Imaging of the Programmed Cell Death-1 Ligand (PD-L1) Using a Zirconium-89 Labeled Therapeutic Antibody, Avelumab.
    Jagoda EM; Vasalatiy O; Basuli F; Opina ACL; Williams MR; Wong K; Lane KC; Adler S; Ton AT; Szajek LP; Xu B; Butcher D; Edmondson EF; Swenson RE; Greiner J; Gulley J; Eary J; Choyke PL
    Mol Imaging; 2019; 18():1536012119829986. PubMed ID: 31044647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immuno-PET Monitoring of CD8
    Alsaid H; Cheng SH; Bi M; Xie F; Rambo M; Skedzielewski T; Hoang B; Mohanan S; Comroe D; Gehman A; Hsu CY; Farhangi K; Tran H; Sherina V; Doan M; Groseclose MR; Hopson CB; Brett S; Wilson IA; Nicholls A; Ballas M; Waight JD; Jucker BM
    Mol Imaging Biol; 2023 Jun; 25(3):528-540. PubMed ID: 36266600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immuno-PET Imaging of
    Li D; Cheng S; Zou S; Zhu D; Zhu T; Wang P; Zhu X
    Mol Pharm; 2018 Apr; 15(4):1674-1681. PubMed ID: 29502426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET imaging facilitates antibody screening for synergistic radioimmunotherapy with a
    Ren J; Xu M; Chen J; Ding J; Wang P; Huo L; Li F; Liu Z
    Theranostics; 2021; 11(1):304-315. PubMed ID: 33391476
    [No Abstract]   [Full Text] [Related]  

  • 16. Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells.
    Rashidian M; Ingram JR; Dougan M; Dongre A; Whang KA; LeGall C; Cragnolini JJ; Bierie B; Gostissa M; Gorman J; Grotenbreg GM; Bhan A; Weinberg RA; Ploegh HL
    J Exp Med; 2017 Aug; 214(8):2243-2255. PubMed ID: 28666979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular imaging of T cell co-regulator factor B7-H3 with
    Burvenich IJG; Parakh S; Lee FT; Guo N; Liu Z; Gan HK; Rigopoulos A; O'Keefe GJ; Gong SJ; Goh YW; Tochon-Danguy H; Scott FE; Kotsuma M; Hirotani K; Senaldi G; Scott AM
    Theranostics; 2018; 8(15):4199-4209. PubMed ID: 30128047
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Heskamp S; Raavé R; Boerman O; Rijpkema M; Goncalves V; Denat F
    Bioconjug Chem; 2017 Sep; 28(9):2211-2223. PubMed ID: 28767228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical Evaluation of
    Maresca KP; Chen J; Mathur D; Giddabasappa A; Root A; Narula J; King L; Schaer D; Golas J; Kobylarz K; Rosfjord E; Keliher E; Chen L; Ram S; Pickering EH; Hardwick JS; Rejto PA; Hussein A; Ilovich O; Staton K; Wilson I; McCarthy TJ
    Mol Imaging Biol; 2021 Dec; 23(6):941-951. PubMed ID: 34143379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of Activated T Cells as an Early Predictor of Immune Response to Anti-PD-1 Therapy.
    Levi J; Lam T; Goth SR; Yaghoubi S; Bates J; Ren G; Jivan S; Huynh TL; Blecha JE; Khattri R; Schmidt KF; Jennings D; VanBrocklin H
    Cancer Res; 2019 Jul; 79(13):3455-3465. PubMed ID: 31064845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.